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Abstract  
The aim of this study was to investigate local opioid effects in the inflamed skin of 
healthy human volunteers. To induce inflammation, the circular tip of a 10-mm diameter 
probe was heated to 48ºC and applied for 120 s to a site on each forearm of 24 healthy 
participants. Thirty minutes later, 0.2 mL normal saline was injected subcutaneously into 
one inflamed site, and the opioid antagonist naloxone hydrochloride (80 µg in 0.2 mL) 
was injected subcutaneously into the other inflamed site. Participants completed tests of 
pain sensitivity (heat pain thresholds, heat pain ratings and mechanical pain ratings) 
before and after the injections. Fentanyl citrate (10 µg in 0.2 mL) was then injected into 
the pre-treated sites, and pain sensitivity was measured again. The thermal injuries 
produced thermal and mechanical hyperalgesia which did not differ between the saline 
and naloxone sites. After the fentanyl injections, decreases in thermal and mechanical 
hyperalgesia were greater at the saline site than the naloxone site. These findings 
demonstrate that pre-treatment with naloxone blocks local opioid effects produced by the 
subcutaneous injection of a low dose of fentanyl in the inflamed skin of healthy humans. 
Thus, peripheral opioid receptors could be a therapeutic target for painful cutaneous 
disorders. 
Perspective: This article demonstrates that activation of opioid receptors in the skin 
inhibits sensitivity to painful mechanical and thermal stimuli. Thus, local application of 
low-dose opioid medications could relieve painful skin disorders. 
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Introduction 
Opioids are usually administered systemically to control pain. However, opioid 
receptors are known to be present on cutaneous sensory nerves in rats
19 and humans.
18 
The peripheral administration of opioids has been found to produce analgesia without 
systemic side effects in animals
15 and humans in response to clinical
4,12 and 
experimentally induced pain.
7,14 Peripherally administered opioids produce negligible 
analgesia in uninflamed tissue but potent analgesia in inflamed tissue.
19  
Experimental procedures that do not injure tissue, such as intradermal injection or 
topical application of low doses of capsaicin,
7,8 sensitize nociceptors and have been 
useful models of neurogenic inflammation. However, procedures that damage tissue, 
such as burning the skin,
16 freezing the skin or pinching the interdigital web,
5,6 more 
closely represent inflammatory pain. Experimentally-induced cutaneous burns produce 
reliable effects on pain sensitivity, the magnitude of which is repeatable within 
participants.
16 Controlled burns induce thermal hyperalgesia and can also evoke 
mechanical hyperalgesia, but this appears to require a more severe burn than hyperalgesia 
to heat.
2  
Opioids administered following experimentally-induced burn injury in humans 
consistently reduce burn-induced hyperalgesia.
9,14 Such antihyperalgesia appears to be 
more pronounced for thermal than mechanical stimuli. Koppert et al.
9 examined the effect 
of peripheral opioids in skin burnt by ultraviolet irradiation. One day after the induction 
of inflammation, the blood supply to the arm was limited by the inflation of a pressure 
cuff to ensure that any opioid effect was peripheral. Morphine hydrochloride (4 mg in 40 
mL) was then administered intravenously to the burnt site. Morphine reduced thermal Page 4 of 20 
pain but not mechanical pain sensitivity, an effect that apparently was mediated by a local 
mechanism because the concentration of morphine and morphine metabolites in the 
systemic circulation was insufficient to have induced analgesia centrally. Moiniche, Dahl, 
and Kehlet
14 investigated the antinociceptive effect of 2 mg morphine injected 
subcutaneously at a site of thermal injury. Approximately 30 min later, thermal and 
mechanical pain thresholds were greater at the morphine site than at a burnt site injected 
with saline. In addition, most participants reported that the morphine-treated site was less 
sensitive than the saline-treated site.  
The antihyperalgesia described in these studies was assumed to be the product of 
peripheral opioid receptor activation. However, this must remain speculative in the 
absence of studies demonstrating blockade of antihyperalgesia by an opioid receptor 
antagonist. Thus, the aim of the present study was to determine whether the opioid 
receptor antagonist naloxone would block the local antihyperalgesic effect of the mu-
opioid receptor agonist fentanyl in the inflamed skin of healthy volunteers. It was 
hypothesized that the subcutaneous injection of fentanyl into burnt skin would reduce 
hyperalgesia to thermal and mechanical stimuli, and that pre-treatment with naloxone 
would reduce the potency of this antihyperalgesia. 
Methods 
Participants 
Participants were 24 healthy volunteers (nine men and 15 women) whose ages 
ranged from 17 to 39 yr (median = 25.5 yr). Participants were advised not to drive a car 
for 6 hours following the procedures, and were reimbursed a small sum of money for 
their time and travel costs. Exclusion criteria were pregnancy and narcotic addiction, Page 5 of 20 
which were assessed by self report. Participants gave written informed consent to 
complete the procedures, which were approved by the ethics committee at the University 
of Western Australia. 
Procedure  
Room temperature ranged between 22.6 and 26.1ºC (M = 24.2 ºC). Two test sites, 
8 and 15 cm proximal to the crease of the wrist on the dorsal aspect of each arm, were 
marked with ink. A burn injury was produced at the distal site on each arm in half of the 
participants (selected at random), and at the proximal site in the remainder. A purpose-
built thermocouple-controlled cautery unit was used to produce burn injuries. The 
circular tip of a 10-mm diameter probe was heated to 48ºC and applied for 120 s with a 
force of approximately 1 N to one site on each arm.
2 Participants were given a 30-min 
break to allow pain sensitivity to stabilize. 
Heat pain thresholds (HPTs) were measured using a heat lamp which directed 
radiant heat from a halogen globe through a lens and circular aperture (1.1 cm in 
diameter) onto the skin. Skin temperature was measured by a thermistor, which was 
positioned under an aluminum shield in the center of the aperture. The arm of the lamp 
could be adjusted to allow the thermistor to touch the skin lightly without transferring the 
weight of the lamp. Skin temperature was held at a baseline of 35.6ºC for 10 s and then 
increased linearly by 0.5ºC/s. In the hand contralateral to the stimulated arm, participants 
held a button which they were instructed to press when they first felt pain. The lamp 
switched off when the button was pressed or the temperature reached 47ºC. The HPT 
estimate was the temperature at which the lamp switched off. Two HPT estimates were Page 6 of 20 
conducted at each site, with a third administered if the first two differed by more than 2ºC 
(14% of trials). For each site, the mean of the 2-3 HPT estimates was recorded.  
Heat pain ratings (HPRs) were made in response to the application of the heat 
lamp at 45ºC for 5 s. Participants rated pain severity using a computerized  10-cm visual 
analogue scale (VAS), marked only with the endpoints “no pain” and “worst pain ever”. 
Ratings were measured to the closest mm. Mechanical pain ratings (MPRs) were made in 
response to the application of a standard von Frey filament with a bending threshold of 
121 mN. To increase sharpness, the angle at the tip of the filament was decreased to 
approximately 45º, reducing the contact surface area to about 0.5 mm
2. Participants rated 
pain on the computerized VAS in response to a single application of the von Frey 
filament for approximately 1 s on each trial. Two HPR and MPR trials were conducted on 
each measurement occasion, and the mean rating at each site was recorded.  
Participants were initially given four practice trials of HPTs, HPRs, and MPRs at 
non-test sites. Participants wore an eye mask during stimulus delivery. Baseline pain-
sensitivity measurement began 30 min after the first burn injury at the burnt sites and an 
untreated site on each arm. 
Participants then washed their forearms with soap and warm water and dried them 
with a paper towel. Burn sites were further cleaned with an alcohol wipe, and 0.2 mL 
normal saline was injected subcutaneously into one burn site and naloxone hydrochloride 
(David Bull Laboratories, 80 µg in 0.2 mL) into the other. Injections were administered 
double-blind and randomized to prevent order effects. Pain sensitivity measures 
commenced five minutes after the injections to determine whether naloxone alone had 
any effect on local pain sensitivity. Fentanyl citrate (Sigma, 10 µg in 0.2 mL normal Page 7 of 20 
saline) was then injected subcutaneously into each burn site. Injections were administered 
subcutaneously to avoid the bleb produced by intradermal injections which might 
interfere with pain sensitivity measures. Subcutaneous injections have been used 
previously to investigate local opioid effects.
14 The 10 µg dose of fentanyl in 0.2 mL 
saline was based on extensive pilot studies that established that a smaller dose or a 
greater injection volume was ineffective in countering hyperalgesia.
17 The 80 µg dose of 
naloxone was also based on pilot studies.
17 In humans, systemic administration of high 
doses of naloxone (7.5 and 10 mg) induces hyperalgesia whereas low doses (0.4 and 2 
mg) induce analgesia;
10 however, very low doses (40 µg) have no systemic effect.
20 Local 
injection of naloxone at doses as low as 5 µg in the inflamed rat paw blocks the local 
antihyperalgesic effect of opioid agonists.
1 Pain sensitivity was measured again at the 
experimental sites starting 5 min after the fentanyl injections. Total testing duration was 
approximately 1.75 hr. 
All HPT, HPR, and MPR data are displayed as means ± standard error of the 
mean. Separate 2 (drug: saline pre-treatment, naloxone pre-treatment) x 2 (phase: before 
and after fentanyl) repeated measures analyses of variance were conducted to investigate 
changes in HPT, HPR, and MPR after the fentanyl injections. Significant drug x phase 
interactions were investigated further with paired t-tests, to determine whether the 
antihyperalgesic effect of fentanyl was greater at the saline-pretreated site than the 
naloxone-pretreated site. A Bonferroni correction was not necessary for these t-tests 
because only two sites were compared. 
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Results 
Effect of burn injury on pain sensitivity 
As shown in Table 1, the burn injuries produced moderate hyperalgesia to heat 
and weak hyperalgesia to mechanical stimulation. In particular, the mean HPT at the 
burnt sites was lower than the mean HPT at the untreated sites, and the mean HPR and 
MPR at the burnt sites were greater than the mean HPR and MPR at the untreated sites. 
The effect of the burn injury on thermal and mechanical pain sensitivity was consistent 
across both burnt sites.  
Effect of fentanyl on pain sensitivity at sites pre-treated with saline or naloxone 
The HPT did not differ significantly between the saline and naloxone sites before 
the fentanyl injections, but the HPT increased after the fentanyl injections at the site pre-
treated with saline (Figure 1). The main effect of phase was significant, F (1,23) = 5.93, p 
< .05, showing that, overall, HPT increased from pre- to post-fentanyl injections. This 
main effect was subsumed within a significant drug by phase interaction, F (1,23) = 6.74, 
p < .05, indicating a differential effect of the fentanyl injection at the saline and naloxone 
sites on HPTs. The HPT increased significantly from pre- to post-fentanyl injection at the 
saline site (M [pre-fentanyl] = 42.1ºC, M [post-fentanyl] = 42.9ºC), t (23) = 4.64, p < 
.001, but not at the site pre-treated with naloxone. 
The HPR did not differ significantly between the saline and naloxone sites before 
or after the fentanyl injections (Figure 2). The main effect of phase approached 
significance, F (1,23) = 4.11, p = .05, suggesting an overall reduction in HPRs from pre- 
to post-fentanyl injection. The interaction between drug and phase was not significant, F Page 9 of 20 
(1,23) = 2.30, p = .14, providing no evidence that the reduction in HPRs following the 
fentanyl injections differed between the saline and naloxone sites.  
The MPR did not differ significantly between the saline and naloxone sites before 
the fentanyl injections (Figure 3). Following the fentanyl injections, the mean MPR 
decreased at the saline site (M [pre-fentanyl] = 2.9 cm, M [post-fentanyl] = 2.5 cm) 
relative to the naloxone site (M [pre-fentanyl] = 2.7 cm, M [post-fentanyl] = 2.8 cm), 
interaction between drug and phase, F (1,23) = 5.37, p < .03. The MPR reduction from 
pre- to post-fentanyl approached significance at the saline site, t (23) = 1.92, p = .07, 
whereas the increase was not significant at the naloxone site. These results indicate that 
fentanyl reduced MPRs when injected at a burnt site pre-treated with saline relative to a 
burnt site pre-treated with naloxone.  
Discussion 
The main finding of the present study was that local pre-treatment with the opioid 
antagonist naloxone blocked the antihyperalgesic effects of the mu-opioid agonist 
fentanyl on HPT and MPR. However, contralateral pre-treatment with naloxone did not 
block the antihyperalgesic effects of fentanyl. Thus, the antihyperalgesia induced by 
fentanyl apparently was mediated locally by mu-opioid receptors on peripheral 
nerves.
18,19 These findings are consistent with research conducted on non-human species 
that identified peripheral opioid effects in inflamed and burnt skin.
15,19 Our procedures 
did not permit us to ascertain whether the injections of fentanyl also acted centrally to 
inhibit pain. However, this seems unlikely because hyperalgesia did not decrease 
significantly at the naloxone-pretreated site after the fentanyl injections.  Page 10 of 20 
We chose to employ a mild burn to avoid tissue damage and blisters that might 
complicate the interpretation of findings. In contrast, Moiniche et al.
14 heated the skin to 
49
oC for 5 minutes, resulting in blisters and second-degree burns. Koppert et al.
9 
irradiated the skin with ultraviolet B light and studied the resultant hyperalgesia 24 hours 
later. To ensure that intravenously administered morphine did not exert any systemic 
effect, the blood supply to the hyperalgesic limb was blocked for 20 min with a cuff at 
250 mm Hg while pain sensitivity was determined. Cuff pressure may have had effects 
on pain sensitivity that were independent from those of ultraviolet irradiation (e.g., 
potentiation of hyperalgesia due to accumulation of lactic acid, or attenuation of 
hyperalgesia due to pressure block of peripheral nerves). Furthermore, the use of 
morphine in both of these studies complicates the methodology as morphine induces mast 
cell degranulation and consequent pro-inflammatory effects.
3,11 Despite these 
methodological shortcomings, morphine clearly inhibited thermal hyperalgesia in burnt 
skin.  
The present results extend these findings by demonstrating that fentanyl-induced 
antihyperalgesia was mediated peripherally by opioid receptors. Pre-treatment of burnt 
skin with a subcutaneous injection of naloxone reduced the antihyperalgesic potency of 
fentanyl for HPTs and MPRs. Naloxone weakened the antihyperalgesic effects of 
fentanyl locally but not in the contralateral arm, providing strong evidence that the 
antihyperalgesic effects of fentanyl were mediated by opioid receptors on peripheral 
nerves. However, hyperalgesia did not differ between sites immediately following the 
naloxone and saline injections, implying that there was insufficient release of endogenous 
opioids in the skin to influence pain sensitivity. Page 11 of 20 
The HPT increased almost 1
oC after the 10 µg fentanyl injection at the saline-
pretreated site. Moiniche et al.
14 also reported that the HPT increased by approximately 
1
oC after subcutaneous injection of 2 mg morphine in burnt skin, whereas Koppert et al.
9 
found that the HPT increased by around 1
oC in moderately inflamed skin and 2
oC in 
more severely inflamed skin ten minutes after intravenous regional injection of 4 mg 
morphine. In contrast, naloxone did not influence HPRs after the fentanyl was injected, 
suggesting that HPRs are less sensitive to local opioid effects than HPTs.   
One limitation of the present study is that the sample was too small to investigate 
gender differences in the response to fentanyl. This might be important, because females 
appear to be more sensitive than males to drugs that act at opioid receptors.
21 Another 
limitation is that the 2-min application of a 48ºC heat probe produced weak mechanical 
hyperalgesia and only moderate thermal hyperalgesia. A more severe thermal injury that 
better resembles clinical pain conditions might allow a clearer demonstration of 
peripheral opioid blockade, particularly for mechanical hyperalgesia.  
Although pharmacological blockade of local opioid-mediated antihyperalgesia 
has been demonstrated in rodents,
15 to our knowledge this is the first demonstration that 
opioid-receptor blockade antagonizes the local antihyperalgesic effects of fentanyl in 
healthy humans with experimentally-induced pain. Thus, the induction of burn injuries 
produced by the 2-min application of a 48ºC probe can be used as a model of 
inflammatory pain in healthy humans that allows locally administered opioids to activate 
peripheral opioid receptors. Compared to studying peripheral nociceptive mechanisms in 
individuals with clinical pain, the study of peripheral opioid analgesia in pain-free 
humans allows greater control over the injury, is cheaper to conduct, and provides greater Page 12 of 20 
experimental sensitivity because participants can serve as their own control. Such a 
model would allow further investigation of the conditions under which the peripheral 
opioid system is active in healthy humans. Furthermore, this study supports the efficacy 
of peripherally applied opioids for the relief of localized inflammatory pain.
13 Further 
clinical studies are needed to investigate the therapeutic effect of subcutaneously 
administered fentanyl for individuals with painful cutaneous disorders. Page 13 of 20 
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Table 1 
Effect of the thermal injury on thermal and mechanical hyperalgesia 
  Mean + S.E.  t-test 
  Burnt Sites  Unburnt sites  (23 d.f.) 
Heat pain threshold (
oC)  41.42 + .41  43.55 + .42        7.55 *** 
Heat pain rating (cm)  3.38 + .52  1.42 + .30        6.00 *** 
Mechanical pain rating (cm)  2.05 + .37  1.77 + .34        2.31 * 
Difference between the burnt and unburnt sites statistically significant: *** p<0.001; * 
p<0.05Page 17 of 20 
 
Figure legends 
Figure 1. Mean heat pain threshold (in ºC) at a burnt site treated with saline and then 
fentanyl, and a burnt site on the contralateral arm treated with naloxone and then 
fentanyl. The heat pain threshold increased significantly after the fentanyl injection at the 
site pre-treated with saline (* p<0.001) but not at the site pre-treated with naloxone. In 
Figures 1-3, error bars represent ± 1 standard error of the mean (n = 24). 
Figure 2. Mean heat pain rating (on a 10-cm VAS) to a 45
oC stimulus for 5 s at a burnt 
site treated with saline and then fentanyl, and a burnt site on the contralateral arm treated 
with naloxone and then fentanyl.  
Figure 3. Mean mechanical pain rating (on a 10-cm VAS) to a 121 mN bristle at a burnt 
site treated with saline and then fentanyl, and a burnt site on the contralateral arm treated 
with naloxone and then fentanyl. After the fentanyl injection, the mechanical pain rating 
decreased at the saline-pretreated site relative to the naloxone-pretreated site (p<0.05).  Page 18 of 20 
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